Genetic Testing & Diagnostics
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 NTRA | Natera, Inc. Common Stock | $26.5b | $204.03 | +1.4% | 1.0M |
 LH | Labcorp Holdings Inc. | $21.7b | $263.80 | -0.4% | 494.4K |
 ILMN | Illumina Inc | $18.5b | $127.94 | +2.0% | 886.6K |
 QGEN | QIAGEN N.V. | $8.1b | $38.41 | +1.2% | 1.2M |
 BLLN | BillionToOne, Inc. Class A Common Stock | $3.2b | $85.00 | +1.3% | 234.7K |
 TXG | 10x Genomics, Inc. Class A Common Stock | $2.5b | $22.09 | +3.1% | 1.6M |
 VCYT | Veracyte, Inc. | $2.4b | $34.34 | +3.6% | 635.4K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.7b | $68.46 | +3.4% | 457.2K |
 NEO | NeoGenomics, Inc. | $0.9b | $8.29 | +4.8% | 1.3M |
 AZTA | Azenta, Inc. | $0.9b | $25.92 | +3.2% | 825.1K |
 CDNA | CareDx, Inc. | $0.8b | $21.23 | +5.8% | 570.7K |
 OPK | Opko Health Inc. | $0.8b | $1.23 | +0.8% | 1.8M |
 PSNL | Personalis, Inc. Common Stock | $0.7b | $6.09 | +3.2% | 2.4M |
 FLGT | Fulgent Genetics, Inc. Common Stock | $488.1m | $16.32 | +1.8% | 277.5K |
 MLAB | Mesa Laboratories Inc | $470.0m | $98.15 | +1.3% | 143.8K |
 MYGN | Myriad Genetics Inc | $407.7m | $4.78 | -0.2% | 735.8K |
 PACB | Pacific Biosciences of California, Inc. | $380.5m | $1.56 | -0.3% | 11.4M |
 PRE | Prenetics Global Limited Class A Ordinary Share | $335.7m | $18.29 | +4.5% | 165.9K |
 ALPS | ALPS Group Inc Ordinary Share | $161.7m | $0.95 | +3.8% | 3.9K |
 IMDX | Insight Molecular Diagnostics Inc. Common Stock | $82.0m | $3.83 | +8.7% | 283.9K |
 BNGO | Bionano Genomics, Inc. Common Stock | $12.5m | $1.21 | 0.0% | 94.2K |
 BGLC | BioNexus Gene Lab Corp Common stock | $5.5m | $2.18 | -2.2% | 4.2K |
 QUCY | Mainz Biomed N.V. Ordinary Shares | $5.2m | $0.50 | -1.7% | 84.2K |